Latest News

Yesterday
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia … GlobeNewswire (Press Release)11:32 9-Dec-23
New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra… Business Wire (Press Release)11:31 9-Dec-23
AbbVie’s $8.7B neuro gambit; Landmark sickle cell approvals; Roche buys a GLP-1 company; Endpoints 100 biotech survey;… ENDPOINTS06:09 9-Dec-23
In the last 7 days
Roche Obtains Positive Data on Early-Stage Breast Cancer Treatment MarketWatch12:31 8-Dec-23
Roche's Inavolisib Breast Cancer Drug Gets Positive Results MarketWatch12:16 8-Dec-23
Roche touts full data for drug in first-line PIK3CA-mutated breast cancer ENDPOINTS12:02 8-Dec-23
Roche's Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive … GlobeNewswire (Press Release)11:54 8-Dec-23
Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone… GlobeNewswire (Press Release)11:49 8-Dec-23
NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate… Business Wire (Press Release)08:03 8-Dec-23
Schroders Capital notes Roche buys portfolio firm for USD2.7 billion London South East06:31 8-Dec-23
Roche's double-antibody DLBCL treatment Columvi nabs Korean nod Korea Biomedical Review01:54 8-Dec-23
BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in Assessing AKI Risk for… GlobeNewswire (Press Release)16:29 7-Dec-23
Global Tyrosine Kinase Inhibitors Market Report 2023-2028, Featuring Profiles of Major Players… PR Newswire (Press Release)14:15 7-Dec-23
Roche shares positive late-stage results for inavolisib combination in advanced breast cancer PMLiVE07:23 7-Dec-23
Adeno-Associated Virus Vectors in Gene Therapy Market to Grow Significantly by 2032 | Biomarin… Industry Today08:27 6-Dec-23
Roche buys Telavant and its IBD drug for $7.1 billion Chemical & Engineering News03:20 6-Dec-23
Roche Buys Carmot Therapeutics to Compete in Booming Market for Weight-Loss Drugs Investopedia15:04 5-Dec-23
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III Zacks13:04 5-Dec-23
Roche Gets Phase III Breast Cancer Victory for Inavolisib Combo BioSpace11:52 5-Dec-23
AbbVie’s new AI deal; Roche's PhIII win in breast cancer; SpringWorks to raise $275M ENDPOINTS11:21 5-Dec-23
Obesity deals come into focus after Roche shells out $2.7B for Carmot ENDPOINTS11:11 5-Dec-23
FDA Puts Clinical Hold on Roche BTK Inhibitor Multiple Sclerosis Program BioSpace07:47 5-Dec-23
Roche to advance novel obesity and diabetes treatments European Pharmaceutical Review07:39 5-Dec-23
Roche reports positive Phase III data for breast cancer therapy Clinical Trials Arena06:48 5-Dec-23
Roche bounces back in PIK3 with inavolisib data pharmaphorum06:30 5-Dec-23
Roche Says Experimental Breast Cancer Drug Helps Patients BNN Bloomberg03:05 5-Dec-23
Roche's inavolisib shows promise in breast cancer study Investing.com02:25 5-Dec-23
Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study MarketWatch01:30 5-Dec-23
Roche announces positive Phase III results for inavolisib combination in people with advanced hormone… GlobeNewswire (Press Release)01:03 5-Dec-23
Genentech Announces Positive Phase III Results for Inavolisib Combination in People With… Business Wire (Press Release)01:02 5-Dec-23
Roche Elbows into Weight-Loss Drug Market Via M&A Power Corridor18:40 4-Dec-23
‘Dualing’ obesity drugs: Roche’s $2.7B buyout of Carmot driven by Mounjaro twin mechanism BioWorld17:14 4-Dec-23
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market Benzinga16:42 4-Dec-23
Roche's BTK inhibitor put on partial hold over concerns about potential liver injury ENDPOINTS15:19 4-Dec-23
Roche Will Buy Obesity And Diabetes Drugmaker Carmot Therapeutics In $2.7 Billion Deal Forbes14:31 4-Dec-23
Roche to Acquire Carmot Therapeutics for Up to $3.1B Genetic Engineering and Biotechnology News14:17 4-Dec-23
Roche to acquire obesity drugmaker Carmot Therapeutics for up to US$3.1B Proactive Investors (Canada)13:13 4-Dec-23
Roche Looks To Muscle Into Obesity Market With $2.7bn Carmot Buyout Scrip Pharma Intelligence12:15 4-Dec-23
Weight-Loss Boom Gets a New Player as Roche Buys Biotech With Hunger Drug in Its Pipeline The Messenger11:35 4-Dec-23
Roche is buying Carmot to enter anti-obesity market Invezz11:32 4-Dec-23
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B Zacks11:07 4-Dec-23
Roche buys weight-loss pill maker Carmot Therapeutics Taipei Times10:44 4-Dec-23
Obesity-Drug Investors Get Windfall as Roche Joins Frenzy (1) Bloomberg Law10:23 4-Dec-23
Roche joins the pharma gold rush after buying an obesity drug for $3bn Irish Examiner09:47 4-Dec-23
Obesity Drug Investors Get Windfall After Roche Buys Into Frenzy BNN Bloomberg09:47 4-Dec-23
Roche enters obesity market with Carmot takeover but drugs may not be available until 2030 CNBC09:46 4-Dec-23
Roche Jumps into Lucrative Weight-Loss Space with $2.7B Carmot Buy BioSpace09:25 4-Dec-23
STAT Plus: Pharmalittle: Roche to buy obesity-drug developer for $2.7 billion; Novo Nordisk… STAT09:19 4-Dec-23
Roche takes on weight-loss drug firms Financial Mail09:17 4-Dec-23
Roche joins obesity drug chase with $2.7B deal for startup Carmot BioPharma Dive09:03 4-Dec-23
Roche to buy obesity drug developer Carmot for up to $3.1bn ShareCast08:47 4-Dec-23
Q+A: Roche’s Nicole Arming and Stefano Volonté on personalised medicine’s potential Verdict Medical Devices08:45 4-Dec-23
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs Benzinga08:23 4-Dec-23
Roche to acquire obesity drug maker Carmot in $3.1 billion deal Investing.com07:55 4-Dec-23
Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It Hopes to Compete with Eli Lilly, Novo Nordisk. Barron's Online07:53 4-Dec-23
KRAS Inhibitor Market to grow significantly by 2032 | Novartis, Roche, Genentech, Verastem… Industry Today07:46 4-Dec-23
Intrahepatic Cholangiocarcinoma Market to grow significantly by 2032 | Incyte Corporation,… Industry Today07:46 4-Dec-23
Roche weighs in on obesity drug market with $2.7bn Carmot buy BioProcess Insider07:46 4-Dec-23
Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn PMLiVE07:41 4-Dec-23
Companies roundup: A bid for 888 and new energy listing Investors Chronicle07:03 4-Dec-23
Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- Update MarketWatch06:06 4-Dec-23
Roche To Buy Cooley-Led US Drugmaker For Up To $3.1B Law36005:59 4-Dec-23
Roche acquires obesity drug developer Carmot Therapeutics for $3.1bn NewsBytes05:47 4-Dec-23
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s… MarketWatch05:44 4-Dec-23
In-Vitro Diagnostics Products Market Seeking Excellent Growth| DiaSorin, Roche Diagnostics,… Industry Today05:43 4-Dec-23
Roche to acquire Carmot Therapeutics for $2.7bn Pharmaceutical Technology05:41 4-Dec-23
Roche to Buy Obesity Drug Maker Carmot for $3.1 Billion (2) Bloomberg Law05:27 4-Dec-23
Roche buys obesity and diabetes biotech Carmot Therapeutics in $2.7B merger deal ENDPOINTS04:49 4-Dec-23
Roche makes obesity play with $2.7bn deal to buy Carmot pharmaphorum04:24 4-Dec-23
Roche Enter Obesity Market with Carmot Deal European Pharmaceutical Manufacturer03:43 4-Dec-23
Roche enters obesity drug market with Carmot deal RTE03:29 4-Dec-23
Roche to Buy Carmot Therapeutics for $2.7 Billion The Wall Street Journal02:55 4-Dec-23
Roche Buys Obesity Drug Developer Carmot for Up to $3.1 Billion BNN Bloomberg02:38 4-Dec-23
STAT Plus: Roche to acquire obesity-focused Carmot Therapeutics for $2.7 billion STAT02:11 4-Dec-23
Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln MarketWatch01:21 4-Dec-23
Roche to acquire Carmot Therapeutics for $2.7 bln Reuters01:20 4-Dec-23
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets… GlobeNewswire (Press Release)01:08 4-Dec-23
Carmot Therapeutics Enters into Definitive Merger Agreement with Roche GlobeNewswire (Press Release)01:04 4-Dec-23
In the last month
PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor for the… Business Wire (Press Release)12:41 1-Dec-23
Artificial intelligence paves way for new medicines Tech Xplore10:05 30-Nov-23
ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target GlobeNewswire (Press Release)08:10 30-Nov-23
Roche Diagnostics CTO: Collaboration is key catalyst for healthcare innovation Korea Biomedical Review20:51 29-Nov-23
Metastatic HER2-Positive Breast Cancer Market to Grow by 2032 at a 5.2% CAGR | DelveInsight PR Newswire (Press Release)17:04 29-Nov-23
Triple-Negative Breast Cancer Market to Grow Rapidly During the Forecast Period (2023–2032), Predicts DelveInsight |… GlobeNewswire (Press Release)13:05 28-Nov-23
Roivant’s Matt Gline on raising capital and biotech’s outlook in 2024 BioPharma Dive08:58 28-Nov-23
Roche rolls out Elecsys HBeAg quant test to detect chronic hepatitis B NS Medical Devices06:47 28-Nov-23
Roche Sells Euro Bonds in Further Funding for Telavant Deal (1) Bloomberg Law13:49 27-Nov-23
Global Glioma Treatment Market Report 2023-2027 and 2032 Featuring Major Players - Merck & Co, Amgen, F Hoffmann-La… GlobeNewswire (Press Release)07:55 27-Nov-23
Aeglea rebrands to Spyre, names new CEO in IBD race against TL1A drugs at Merck, Roche and Sanofi ENDPOINTS07:03 27-Nov-23
Roche Is Selling Euro Bonds in Further Funding for Telavant Deal BNN Bloomberg06:05 27-Nov-23
Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic… GlobeNewswire (Press Release)01:02 27-Nov-23
F. Hoffmann-La Roche sees highest patent filings and grants during August in Q3 2023 Pharmaceutical Technology07:45 24-Nov-23
How Roche enables life-changing innovation IT PRO07:11 23-Nov-23
Cytotoxic Drug Market Is Thriving Worldwide with Roche Holding, Eli Lilly, Celgene, Sanofi Industry Today07:12 22-Nov-23
Roche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AI MarketWatch10:40 21-Nov-23
Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug… Business Wire (Press Release)09:02 21-Nov-23
Roche’s Genentech partners with Nvidia in AI drug deal BioPharma Dive09:02 21-Nov-23
Genentech, Biogen and Hoffmann-La Roche File Lawsuit Over Planned Release of 'Copycat' of Pioneering Cancer Drug Law.com17:16 20-Nov-23
Roche, Biogen Sue Dr. Reddy’s to Block Biosimilar of Rituxan Bloomberg Law15:53 20-Nov-23
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock Zacks11:08 20-Nov-23
Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics… PR Newswire (Press Release)01:01 20-Nov-23
Risk adjusted net present value: What is the current valuation of F. Hoffmann-La Roche’s… Pharmaceutical Technology22:51 18-Nov-23
Selnoflast by F. Hoffmann-La Roche for Coronary Artery Disease (CAD) (Ischemic Heart Disease):… Pharmaceutical Technology20:49 18-Nov-23
Glofitamab by F. Hoffmann-La Roche for Marginal Zone B-cell Lymphoma: Likelihood of Approval Pharmaceutical Technology20:38 18-Nov-23
Selnoflast by F. Hoffmann-La Roche for Chronic Obstructive Pulmonary Disease (COPD): Likelihood … Pharmaceutical Technology14:02 18-Nov-23
Advances in Knee Replacement Surgery Enable More Patients to Go Home the Same Day Newswise (Press Release)13:35 18-Nov-23
Roche rolls out Elecsys Anti-HEV IgM and IgG tests to detect HEV infections NS Medical Devices01:34 17-Nov-23
Basmisanil by F. Hoffmann-La Roche for Dup15q Syndrome: Likelihood of Approval Pharmaceutical Technology22:46 16-Nov-23
Your 6-Week 10K Treadmill Training Plan Runners' World17:21 16-Nov-23
Roche investing $240 million in Colombia over five years - country general manager Reuters12:14 16-Nov-23
Pharma giant Roche ordered to pay whistleblower €8,000 for penalising him over protected disclosure The Irish Times08:54 16-Nov-23
Roche must pay whistleblower €8,000 compensation - WRC RTE08:22 16-Nov-23
BMS gets US approval for ROS1 lung cancer drug Augtyro pharmaphorum05:47 16-Nov-23
Roche launches automated serology hepatitis E virus tests, including a test to detect acute HEV infections, recommended … GlobeNewswire (Press Release)01:03 16-Nov-23
CHMP recommends new immunotherapy delivery method European Pharmaceutical Review10:28 15-Nov-23

      
            
      
    view more headlines
   
      
      
      
9 Dec 11:32
   
Roche News

NewsNow brings you the latest news from the world’s most trusted sources on Roche pharmaceuticals, a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. NewsNow aims to be the world’s most accurate and comprehensive Roche news aggregator, bringing you the latest headlines automatically and continuously 24/7.
Roche

Latest News

Roche News

Pharmaceuticals Top Stories

Business Top Stories
